Propanc Biopharma Inc PPCB

AU Biotechnology

$0.51 ▼ -3.96% ($-0.02)

🎈 Low Float 🎢 High Beta 📅 Earnings This Week

Open $0.52

Prev Close $0.53

Day Range $0.50 – $0.55

52W Range $0.52 – $52.50

Market Cap $1.87M

Beta 3.18

EPS (TTM) $-25.66

📋 Company Profile

Industry	Biotechnology
Country	AU
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2012-06-15
Shares Out.	2,280,000
Website	propanc.com/ ↗
Phone	13023513367
Employees	2
Revenue	$0
Gross Profit	$0
Net Income	-$4.6M
Free Cash Flow	-$5.7M
Total Assets	$12.8M
Total Liabilities	$3.4M
Equity	$9.4M

About Propanc Biopharma Inc

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Propanc Biopharma Inc is a publicly traded company under the ticker symbol PPCB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.